Tuesday, June 11, 2024 2:23:04 PM
Because this stock has been trash for years. This is just the latest scheme and you fools who have bought into it are now upset when I show what is going on using the company's own print. The stock purchase by the CEO's wife would suggest that Ethema Health just got a huge capital infusion. That clearly isn't the case. No new shares have been issued. It looks like she simply used the debt owed to her to price herself some shares at $0.04 and filed it as an insider buy. The last time Ethema Health was able to sell shares was in February 2022 when they did the four press releases in a week so that Leonite could dump $150K worth of shares on retail. See the outstanding share count for June 2022 in the Q2 filing? 3,729,053,805 shares is the same as of June 10 2024. Zero new shares were issued for the CEO's wife according to this information. We will likely see another form 4 by the end of the year showing where she sells the stock for the tax loss. This scheme is one way she can get the loss credit. I want to know why they are promoting this instead of filing an 8K explaining it. I see a SEC complaint developing.
For the quarterly period ended June 30, 2022
https://www.sec.gov/ix?doc=/Archives/edgar/data/0000792935/000190359622000529/sfsgrst10q081122.htm
Page 24
Authorized and outstanding
The Company has authorized 10,000,000,000 shares with a par value of $0.01 per share. The company has issued and outstanding 3,729,053,805 and 3,579,053,805 shares of common stock at June 30, 2022 and December 31, 2021, respectively.
On February 28, 2022, the Company issued 150,000,000 shares of common stock to Leonite in connection with a conversion notice received, converting principal of $149,250.
For the quarterly period ended June 30, 2022
https://www.sec.gov/ix?doc=/Archives/edgar/data/0000792935/000190359622000529/sfsgrst10q081122.htm
Page 24
Authorized and outstanding
The Company has authorized 10,000,000,000 shares with a par value of $0.01 per share. The company has issued and outstanding 3,729,053,805 and 3,579,053,805 shares of common stock at June 30, 2022 and December 31, 2021, respectively.
On February 28, 2022, the Company issued 150,000,000 shares of common stock to Leonite in connection with a conversion notice received, converting principal of $149,250.
Bearish
Everything that I post is just my informed opinion and is simply an invitation to debate. Trade on your own due diligence please..
Recent GRST News
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 04/13/2026 06:50:44 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/30/2026 03:17:00 PM
- DealFlow Discovery Conference Announces Initial Lineup of Presenting Companies Ahead of Next Week's Event • ACCESS Newswire • 01/23/2026 07:50:00 PM
- Small Cap Growth Virtual Investor Conference: Presentations Now Available for Online Viewing • GlobeNewswire Inc. • 12/10/2025 02:57:30 PM
- Small Cap Growth Virtual Investor Conference Agenda Announced for December 9th • GlobeNewswire Inc. • 12/10/2025 01:35:00 PM
- Small Cap Growth Virtual Investor Conference Agenda Announced for December 9th • GlobeNewswire Inc. • 12/05/2025 01:35:00 PM
- Ethema Health to Present at the Small Cap Growth Virtual Investor Conference December 9th • GlobeNewswire Inc. • 12/04/2025 01:35:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 12/03/2025 10:21:56 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/14/2025 05:27:02 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/03/2025 10:25:50 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/17/2025 05:21:14 PM
